Fox News
Radio executive claims innocent reason for €111k cannabis shipment
Two men held over Manchester Jewish terror plot
Over €2m Allocated for Asylum Centre Security
Colorado player apologizes for derogatory remarks about Northwestern's temporary stadium
Senior NATO official warns Putin's increasing recklessness in Ukraine
Source: Fox News
24 HrsReady to play
Ready to play
Hundreds of consumers are suing manufacturers of GLP-1 receptor agonists, alleging these medications may increase the risk of a rare, vision-damaging condition called NAION, or nonarteritic anterior ischemic optic neuropathy. While researchers have identified a potential link, studies are observational and do not confirm causation. The FDA is reviewing the evidence, but currently has not issued safety warnings, whereas European regulators have classified NAION as a "very rare" side effect. Patients are advised to consult their healthcare providers before discontinuing or starting GLP-1 medications.
Notice: This Is an AI-Generated Summary
Comments (0)